Long-term simulation models are often necessary to estimate the benefits and costs of new treatments for sickle cell disease.

The Hutchinson Institute Sickle Cell Disease Outcomes Research and Economics (HISCORE) model is designed to capture patient disease progression and be able to take short- or medium-term effects and extrapolate them across a patient’s lifetime.